LifeMD
LFMD
14 hedge funds and large institutions have $5.79M invested in LifeMD in 2020 Q4 according to their latest regulatory filings, with 14 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
3.8% more ownership
Funds ownership: 0% → 3.8% (+3.8%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
+$3.09M |
| 2 |
GIPM
G2 Investment Partners Management
New York
|
+$1.72M |
| 3 |
BIA
Barry Investment Advisors
New Bedford,
Massachusetts
|
+$610K |
| 4 |
MFG
Magnus Financial Group
New York
|
+$348K |
| 5 |
GIA
Granite Investment Advisors
Concord,
New Hampshire
|
+$293K |
Top Sellers
LFMD Hedge Fund Activity: Q4 2020 in Review
14 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in LifeMD (LFMD) for Q4 2020, worth a combined $5.79M.
Buyers outnumbered sellers: 14 funds opened new LFMD positions and 0 closed out — a net gain of 14 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Monashee Investment Management, opening a new position worth an estimated $3.09M.
- 14 institutional investors held LifeMD (LFMD) as of Q4 2020, up from 0 in Q3 2020.
- Funds reported $5.79M of LifeMD stock for Q4 2020.
- 14 funds opened new LifeMD positions in Q4 2020 and 0 closed out, a net change of +14 holders.
- The largest LifeMD buyer in Q4 2020 was Monashee Investment Management, an estimated $3.09M added.
Based on aggregated 13F filings for Q4 2020.